Brexit: When is a UCITS not really a UCITS?

September 14, 2020
With Brexit firmly back in the news headlines, it is worth revisiting this thorny subject and focus on the impact on asset managers and their respective products.

With Brexit firmly back in the news headlines, it is worth revisiting this thorny subject and focus on the impact on asset managers and their respective products. Since the initial vote, Brexit has been a storyline fraught with ambiguity, uncertainty, and fast-paced changes and as the end of the Brexit transition period and no deal cliff edge approach — this time for real — many asset managers are rightfully already contemplating the post-Brexit landscape. But even when Brexit officially happens, unfortunately the complexity and uncertainty around it will likely remain. 

The Change Over/Change Up

One of the instant effects of the UK leaving the European Union is that UK-based firms cannot act as UCITS management companies. Further, UK domiciled funds who previously were authorized as UCITS instantly become non-EU alternative investment funds (AIFs), as there is no third-country regime for UCITS.

Before we address the points of ambiguity and uncertainty, let’s be crystal clear: as of January 1st, 2021, no UK fund or management company will have UCITS authorization status. Only funds or management companies domiciled in an EU member state are eligible under UCITS and can avail of its passporting permissions.

From an EU perspective, all UK UCITS instantly become non-EU third country Alternative Investment Funds (AIFs): because no “passport” has been switched on for non-EU AIFs (including for UK funds after 1st January), sales and distribution of such funds into the EU will be subject to relevant member state national private placement rules.

While most recent talk has been about UK divergence from EU rules and laws, from a UK funds market perspective, the FCA has already moved to implement some EU exit regulations which in effect “freeze” and retain certain EU laws for funds in the UK for the time being, one of which is retain the UCITS rulebook for UK domiciled funds who currently are authorized as UCITS.

Same, but different

In turn, this has created a rather unhelpful new fund label (“UK UCITS”), to refer to existing UK domiciled UCITS funds or future funds which may launch in the UK under the “onshored” UCITS regime. It is understandable why the UK funds wish to retain this ruleset as it ensures continuity for investors already in the UK UCITS funds and its brand recognition is already strong in the UK market, however it remains quite confusing since there will now be two types of “UCITS” available in the UK funds market. The two versions are:

  1. UK UCITS. These are UK domiciled funds which carry the name but are not part of the pan-European UCITS ecosystem and cannot be distributed cross border under the UCITS regime
  2. UCITS. These are funds domiciled in an EU country that can be sold on a cross border basis across all EU member states and may also continue to be sold into the UK market under the Overseas Fund Regime (OFR)

The continued use of the term “UK UCITS” is also commercially driven as the UK industry looks to maintain a degree of equivalence with EU. The term also creates positive branding by association for UK funds as industry looks to export UK funds into other markets through mutual recognition agreements and memorandum of understandings (MOUs) with other non-EU financial centers. It should be noted that historically UK funds have not exported well even when they had actual UCITS designation. It is still unknown whether the EU retains a trademark for the UCITS designation or if they will take action if certain UK UCITS attempt to leverage the UCITS name to market against EU UCITS in markets throughout Asia for example where the UCITS brand recognition is very strong. It is also far from clear what, if any, powers the EU holds to stop the UK from calling the funds in question UCITS. 

NURS uncertainty remains

The other driver to retain the UCITS designation for certain funds is that a fund in the UK market known as Non-UCITS Retail Schemes (NURS) remains under regulatory scrutiny. The scrutiny is primarily due to liquidity concerns within certain retail property funds and carry over from events in connection with Neil Woodford’s fund. This is causing some managers to question whether they should look to have their NURS re-constituted to become a UK UCITS with the Financial Conduct Authority (FCA). This step further avoids oncoming additional FCA liquidity scrutiny that NURS will be subjected to soon. 

Bottom line

The retention of the UCITS moniker for UK funds shows how successful the brand has been and the trust it instils in investors. Even without the distribution and passporting benefits that EU UCITS benefit from, it will be interesting to see how well the UK UCITS versions do when it comes to attracting inflows. The strength and trust in the UCITS brand are such that the UK has consciously retained it even after leaving the EU. On the other hand, having two versions of UCITS in the UK market and generally will very likely generate some confusion down the line. It truly does raise the question when is a UCITS not a UCITS?

Brown Brothers Harriman & Co. (“BBH”) may be used as a generic term to reference the company as a whole and/or its various subsidiaries generally. This material and any products or services may be issued or provided in multiple jurisdictions by duly authorized and regulated subsidiaries.This material is for general information and reference purposes only and does not constitute legal, tax or investment advice and is not intended as an offer to sell, or a solicitation to buy securities, services or investment products. Any reference to tax matters is not intended to be used, and may not be used, for purposes of avoiding penalties under the U.S. Internal Revenue Code, or other applicable tax regimes, or for promotion, marketing or recommendation to third parties. All information has been obtained from sources believed to be reliable, but accuracy is not guaranteed, and reliance should not be placed on the information presented. This material may not be reproduced, copied or transmitted, or any of the content disclosed to third parties, without the permission of BBH. All trademarks and service marks included are the property of BBH or their respective owners.© Brown Brothers Harriman & Co. 2021. All rights reserved.

This browser is not fully supported by our public website and may not display or function as expected for this reason. Please note, the Infuse Portal and BBH client applications fully support the IE 11 browser.

Important Information for Non-U.S. Residents

You are required to read the following important information, which, in conjunction with the Terms and Conditions, governs your use of this website. Your use of this website and its contents constitute your acceptance of this information and those Terms and Conditions. If you do not agree with this information and the Terms and Conditions, you should immediately cease use of this website. The contents of this website have not been prepared for the benefit of investors outside of the United States. This website is not intended as a solicitation of the purchase or sale of any security or other financial instrument or any investment management services for any investor who resides in a jurisdiction other than the United States1. As a general matter, Brown Brothers Harriman & Co. and its subsidiaries (“BBH”) is not licensed or registered to solicit prospective investors and offer investment advisory services in jurisdictions outside of the United States. The information on this website is not intended to be distributed to, directed at or used by any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation. Persons in respect of whom such prohibitions apply must not access the website.  Under certain circumstances, BBH may provide services to investors located outside of the United States in accordance with applicable law. The conditions under which such services may be provided will be analyzed on a case-by-case basis by BBH. BBH will only accept investors from such jurisdictions or countries where it has made a determination that such an arrangement or relationship is permissible under the laws of that jurisdiction or country. The existence of this website is not intended to be a substitute for the type of analysis described above and is not intended as a solicitation of or recommendation to any prospective investor, including those located outside of the United States. Certain BBH products or services may not be available in certain jurisdictions. By choosing to access this website from any location other than the United States, you accept full responsibility for compliance with all local laws. The website contains content that has been obtained from sources that BBH believes to be reliable as of the date presented; however, BBH cannot guarantee the accuracy of such content, assure its completeness, or warrant that such information will not be changed. The content contained herein is current as of the date of issuance and is subject to change without notice. The website’s content does not constitute investment advice and should not be used as the basis for any investment decision. There is no guarantee that any investment objectives, expectations, targets described in this website or the  performance or profitability of any investment will be achieved. You understand that investing in securities and other financial instruments involves risks that may affect the value of the securities and may result in losses, including the potential loss of the principal invested, and you assume and are able to bear all such risks.  In no event shall BBH or any other affiliated party be liable for any direct, incidental, special, consequential, indirect, lost profits, loss of business or data, or punitive damages arising out of your use of this website. By clicking accept, you confirm that you accept  to the above Important Information along with Terms and Conditions.

 
1BBH sponsors UCITS Funds registered in Luxembourg, in certain jurisdictions. For information on those funds, please see bbhluxembourgfunds.com


captcha image

Type in the word seen on the picture

I am a current investor in another jurisdiction